Marker Therapeutics's market cap is currently $12.29M. The company's EPS TTM is $-0.249; its P/E ratio is ―; Marker Therapeutics is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
